Glass House Brands (GLAS) Receivables - Net (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Receivables - Net of $6.4 million for Q1 2026, down 4.04% year-over-year from $6.7 million in Q1 2025, and up 45.82% quarter-over-quarter from $4.4 million in Q4 2025.
Glass House Brands (GLAS) Receivables - Net (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Receivables - Net for 7 consecutive years, with $6.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Net fell 4.04% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $6.4 million (down 4.04% YoY), while the FY2025 annual figure was $4.8 million, down 7.47% from the prior year.
- Receivables - Net advanced to $6.4 million in Q1 2026 per GLAS's latest filing, from $4.4 million in the prior quarter.
- Across five years, Receivables - Net topped out at $9.8 million in Q2 2025 and bottomed at $2.5 million in Q1 2022.
- Historically, Receivables - Net has averaged $5.4 million across 5 years, with a median of $5.2 million in 2024.
- Annual changes were most pronounced in 2022 — Receivables - Net jumped 154.39% — and 2023, when it tumbled 38.13%.
- Glass House Brands' Receivables - Net stood at $5.2 million in 2022, then decreased by 10.38% to $4.7 million in 2023, then advanced by 11.18% to $5.2 million in 2024, then dropped by 15.4% to $4.4 million in 2025, then soared by 45.82% to $6.4 million in 2026.
- Business Quant data shows GLAS's Receivables - Net at $6.4 million in Q1 2026, $4.4 million in Q4 2025, and $6.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Glass House Brands | 825.81 Mn | 807.26 Mn | 15.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.44 Mn |
| Mar 31, 2026 | 6.44 Mn |
| Dec 31, 2025 | 4.42 Mn |
| Dec 31, 2025 | 4.42 Mn |
| Sep 30, 2025 | 6.14 Mn |
| Sep 30, 2025 | 6.14 Mn |
| Jun 30, 2025 | 9.84 Mn |
| Jun 30, 2025 | 9.84 Mn |
| Mar 31, 2025 | 6.71 Mn |
| Mar 31, 2025 | 6.71 Mn |
| Dec 31, 2024 | 5.22 Mn |
| Dec 31, 2024 | 5.22 Mn |
| Sep 30, 2024 | 7.89 Mn |
| Sep 30, 2024 | 7.89 Mn |
| Jun 30, 2024 | 7.72 Mn |
| Jun 30, 2024 | 7.72 Mn |
| Mar 31, 2024 | 3.01 Mn |
| Mar 31, 2024 | 3.01 Mn |
| Dec 31, 2023 | 4.70 Mn |
| Dec 31, 2023 | 4.70 Mn |